A BRIEF REVIEW ON TREATMENTS OF ALZHEIMER DISEASES

Journal Title: Asian Journal Of Pharmaceutical Research and Development - Year 2017, Vol 5, Issue 2

Abstract

Alzheimer disease is the most common form of the dementia which occurs among older people above the age of 60years. The Alzheimer’s disease once considered a rare disorder and it is now seen as a major public health problem that is seriously affecting millions of older people and their families world over. Alzheimer's is characterized by massive loss of neurons and disrupted signaling between cells in the brain. The disease can be diagnosed post mortem by observing tangles inside and senile plaques outside cells throughout the brain. The first neurotransmitter defect discovered in Alzheimer disease involved acetylcholine (ACh). As cholinergic function is required for short term memory.Traditionally herbal drugs have been used to enhance cognitive functions andto alleviate other functions associate with the AD. A number of medicinal plants per se and medicines derived from these plants have shown memory enhancing properties by virtue of their medicinal constituents. One of the mechanisms suggested to dementia is decreased cholinergic activity in brain.The studies related to clinical trials of drugs in patients with Alzheimer disease have focused on the development of drugs augmenting the level of neurotransmitter acetylcholine in the brain in order to compensate for the loss of cholinergic function. Amongst these drugs, acetylcholine precursors, muscarinic agonists, nicotinic agonists and choline esterase inhibitors have extensively been studied in patients with Alzheimer’s disease and the successful approach to treat this disease have employed acetylcholineesterase (AChE) inhibition. The clinical response of few drugs namely donepezil (Aricept), rivastigmine (Exelon), galantamine (Reminyl) and Memantine (Nemenda) approved by Food and Drug Alzheimer disease ministration (FDA).

Authors and Affiliations

Amit Kumar Viswas

Keywords

Related Articles

FORMULATION DESIGN AND OPTIMIZATION OF ORAL FLOATING MATRIX TABLETS OF CIPROFLOXACIN HCL BY USING HPMC AND XANTHAN GUM WITH EXPERIMENTAL DESIGN

The oral floating matrix tablets of Ciprofloxacin Hydrochloride were formulated by Experimental design by using HPMC K100M and Xanthan gum as the retardant polymers each with three different levels with an approach to in...

DIFFERENT BODY FLUIDS: AN OVERVIEW

The focus of this article is to review the recent advances in proteome analysis of human body fluids, including plasma/serum, urine, cerebrospinal fluid, saliva, bronchoalveolar lavage fluid, synovial fluid, nipple aspir...

PHYTOCHEMICAL STUDY OF AERIAL PART OF DIFFERENT SPECIES OF ZIZIPHUS GENUS

The leaves and barks powder are used as aerial part of Ziziphus ziziphus (l) karst and Ziziphus xyloporus, selected from Ziziphus genus were extracted with 95% ethanol for 48 hours through hot percolation method, total a...

REVIEW ON VENDOR AUDIT MANAGEMENT

Vendor Relationship Management (SRM), is systematic planning and managing of all interactions with suppliers to maximize its value. Its application varies from construction industries to healthcar...

PRESENCE OR ABSENCE OF STONE CELLS IN THE ROOTS OF INDIAN ACONITES: AN AID TO IDENTIFICATION OF SPECIES

The species of the genus Aconitum are commonly and collectively called Aconites in trade. Aconites are known to people since antiquity as deadly poisonous plants. They arebeing used world-wide either as...

Download PDF file
  • EP ID EP303198
  • DOI -
  • Views 144
  • Downloads 0

How To Cite

Amit Kumar Viswas (2017). A BRIEF REVIEW ON TREATMENTS OF ALZHEIMER DISEASES. Asian Journal Of Pharmaceutical Research and Development, 5(2), 1-8. https://europub.co.uk/articles/-A-303198